Division of Rheumatology, Department of Medicine, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, South Korea.
Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Clin Rheumatol. 2019 Jan;38(1):235-241. doi: 10.1007/s10067-018-4256-2. Epub 2018 Aug 9.
Tubulointerstitial inflammation (TI) has prognostic significance in the renal outcomes of lupus nephritis. Here, we aimed to determine whether non-albumin proteinuria is associated with TI severity and with the renal response in lupus nephritis. We included patients with biopsy-confirmed lupus nephritis at a tertiary medical center in Korea from January 2011 to April 2017. Patients in whom the urine protein/creatinine ratio (uPCR) and the urine albumin/creatinine ratio (uACR) were measured simultaneously were included. Laboratory data and renal pathology were reviewed. Non-albumin proteinuria was calculated by subtracting uACR from uPCR. The renal response was assessed by the amount of proteinuria present at 6 months after treatment with immunosuppressants. Logistic regression analyses were performed to identify factors associated with TI severity and renal response. Out of 45 patients, 36 (80%) had no-to-mild TI, whereas 9 (20%) had moderate-to-severe TI. Proliferative (class III ± V/IV ± V) and nonproliferative (class II/V) glomerulonephritis (GN) were present in 38 (84.4%) and 7 (15.6%) patients, respectively. In the logistic regression analyses, non-albumin proteinuria (uPCR - uACR) was associated with moderate-to-severe TI (odds ratio [OR] 3.166, 95% confidence interval [95% CI] 1.145-8.757, p = 0.026) and was inversely associated with complete renal response (adjusted OR 0.180, 95% CI 0.045-0.718, p = 0.015). In lupus nephritis, non-albumin proteinuria was associated with TI severity and with poor renal response after immunosuppressive treatment. Thus, the determination of non-albumin proteinuria can provide clinically valuable information on lupus nephritis.
肾小管间质性炎症(TI)与狼疮肾炎的肾脏结局具有预后意义。在这里,我们旨在确定非白蛋白蛋白尿是否与 TI 严重程度以及狼疮肾炎的肾脏反应相关。我们纳入了 2011 年 1 月至 2017 年 4 月在韩国一家三级医学中心接受肾活检确诊为狼疮肾炎的患者。同时测量尿蛋白/肌酐比值(uPCR)和尿白蛋白/肌酐比值(uACR)的患者被纳入。回顾实验室数据和肾脏病理。通过从 uPCR 中减去 uACR 来计算非白蛋白蛋白尿。通过治疗后 6 个月蛋白尿的量来评估肾脏反应。使用逻辑回归分析来确定与 TI 严重程度和肾脏反应相关的因素。在 45 例患者中,36 例(80%)为无至轻度 TI,9 例(20%)为中重度 TI。增殖性(III 级 ± V/IV 级 ± V)和非增殖性(II 级/V 级)肾小球肾炎分别存在于 38 例(84.4%)和 7 例(15.6%)患者中。在逻辑回归分析中,非白蛋白蛋白尿(uPCR-uACR)与中重度 TI 相关(优势比[OR] 3.166,95%置信区间[95%CI] 1.145-8.757,p=0.026),与完全肾脏反应呈负相关(调整后的 OR 0.180,95%CI 0.045-0.718,p=0.015)。在狼疮肾炎中,非白蛋白蛋白尿与 TI 严重程度以及免疫抑制治疗后肾脏反应不良相关。因此,非白蛋白蛋白尿的测定可以为狼疮肾炎提供有临床价值的信息。